Flunex

Maintains productivity
Cattle
Swine
Other animals
Flunixin meglumine

Nonsteroidal anti-inflammatory drug increasing the antibiotic treatment effectiveness

A powerful analgesic effect

Prolonged effect - 24 hours

Rapid recovery of productive qualities

Anti-inflammatory effect is 16 hours longer as compared to ketoprofen-based preparations

  • Description
  • A nonsteroidal anti-inflammatory drug, which increases the effectiveness of antibiotic treatment. Reduces the recovery period and maintains the productive qualities of pigs and cattle by relieving inflammation and pain.
    Appearance:  a clear yellow solution.
    It is packaged in 100 ml glass vials sealed with rubber stoppers and rubber run-aluminum caps with clips to control the first opening.


    Flunex
  • Composition
  • Composition
    1 ml Flunex  = 50 mg flunixin
  • Pharmacological properties
  • Pharmacological properties

    Flunex is a non-steroidal anti-inflammatory drug. Flunixin, the active substance of this drug, is a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2) activity; it also suppresses the synthesis of E2 prostaglandins that act as inflammatory mediators, thus ensuring its analgesic, anti-inflammatory, antipyretic, and antitoxic activity.

    After parenteral administration, flunixin is quickly absorbed from the injection site and distributed among the organs and tissues of the animal. Its peak blood concentration is reached in 5-45 minutes. The drug accumulates in the focus of inflammation thus prolonging the therapeutic effect up to 24 hours. 99 per cent of flunixin binds with proteins is eliminated mostly with feces and partially with urine.

    According to GOST (State Standard) No. 12.1.007-76, Flunex belongs to the 3rd class hazardous substances (moderately hazardous substances). The drug is well tolerated by animals in the recommended doses and does not cause any embryotoxic, teratogenic and hepatoxic effects.

  • Indications
  • Indications

    Flunex is a non-steroidal anti-inflammatory drug. Flunixin, the active substance of this drug, is a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2) activity; it also suppresses the synthesis of E2 prostaglandins that act as inflammatory mediators, thus ensuring its analgesic, anti-inflammatory, antipyretic, and antitoxic activity.

    After parenteral administration, flunixin is quickly absorbed from the injection site and distributed among the organs and tissues of the animal. Its peak blood concentration is reached in 5-45 minutes. The drug accumulates in the focus of inflammation thus prolonging the therapeutic effect up to 24 hours. 99 per cent of flunixin binds with proteins is eliminated mostly with feces and partially with urine.

    According to GOST (State Standard) No. 12.1.007-76, Flunex belongs to the 3rd class hazardous substances (moderately hazardous substances). The drug is well tolerated by animals in the recommended doses and does not cause any embryotoxic, teratogenic and hepatoxic effects.

  • Dosage and route of administration
  • Dosage and route of administration

    Flunex is administered to cattle 2 mL per 45 kg of body weight once a day intravenously or intramuscularly in case of respiratory diseases, acute mastitis and other diseases involving acute inflammation, depending on the severity of the inflammatory process, to improve clinical condition of the animal, but no more than 5 consecutive days. Flunex is administered 2 mL per 45 kg body weigh to pigs once by a deep intramuscular injection in the neck area in case of the MMA syndrome and respiratory diseases. Flunex is administered to horses intravenously: in case of musculoskeletal system diseases - 1 mL per 45 kg of body weight once a day to improve clinical condition of the animal, but no more than 5 consecutive days; to relieve pain in case of colic – 1 mL per 45 kg of body weight once, if necessary, again after 24 hours; for endotoxemia, septic shock and other diseases associated with blood circulation in the gastrointestinal tract – 0.2 mL per 45 kg body weight every 6-8 hours to reduce the clinical signs of the disease, but no more than 5 injections. If the required volume of the drug exceeds 2.5 mL for smaller animals and 5 mL for bigger animals, several injections into various sites shall be made in order to avoid a possible pain reaction.


  • Restrictions
  • Restrictions

    Slaughter of cattle is allowed not earlier than 8 days after the intravenous and not earlier than 35 days after the intramuscular administration. Slaughter of horses is permitted not earlier than 8 days after the last injection. Slaughter of pigs for meat is permitted not earlier than 24 days after the last injection. Meat from animals slaughtered before the expiry of the stated period, can be used in animal feed. Milk of dairy cows may be used not earlier than 60 hours after the last injection. Milk produced before the expiration of the stated period can be used in animal feed after boiling.

  • Publications
  • Publications
  • Treatment regimen
SIMILAR GOODS
Calcium Borogluconate 20%. Photo

Calcium Borogluconate 20%

Other
composition
200 mg calcium gluconate<br>
18,5 mg boronic acid <br>
13 mg sodium tetraborate
composition
200 mg calcium gluconate<br>
18,5 mg boronic acid <br>
13 mg sodium tetraborate
Caffeine-sodium benzoate 20%. Photo

Caffeine-sodium benzoate 20%

Other
composition
75 mg caffeine <br>
125 mg sodium benzoate

composition
75 mg caffeine <br>
125 mg sodium benzoate

Back to the list